The purpose of the scan is to check the baby's heartbeats and identify whether the pregnancy is single, a twin, or multiple. In rare cases, if foetal development occurs outside the uterus (ectopic pregnancy), timely diagnosis and treatment can be initiated following this scan.

Between 11 and 14 weeks, we closely monitor the baby's heartbeats and growth, providing valuable insights into the pregnancy. This scan confirms whether the pregnancy is single, twin, or multiple.

By this stage, it is also possible to see the baby's head, spine, hands, feet, stomach, bladder, heart, and most organs, allowing us to ensure that everything is normal.

There is a fluid at the back of the foetal neck called nuchal translucency (NT). Measuring nuchal translucency helps assess the likelihood of chromosomal abnormalities, such as foetal aneuploidy. When combined with a blood test—such as the double marker test or NIFTY test—the NT measurement provides a more accurate evaluation of the foetus's chromosomal health, offering a clear risk assessment.

In the case of a twin pregnancy, it helps to determine whether the twins share one placenta or have two separate placentas. If they share a single placenta, this type of pregnancy requires specialized care to monitor the health and well-being of both the mother and the babies.

Pre-eclampsia is a pregnancy-related condition caused by high blood pressure and can be life-threatening. It affects approximately 1 in 20 pregnant women. Early detection is crucial, as timely treatment can protect both mother and baby and improve pregnancy outcomes. Pre-eclampsia screening is performed during the first trimester to identify early-onset pre-eclampsia.

The screening is offered in conjunction with the NT scan, ensuring a comprehensive approach to monitoring your pregnancy health.

This scan offers a detailed view of the internal and external anatomy, enabling the identification of defects, subtle chromosomal abnormalities, and potential genetic syndromes.

It gives detailed images of the head, face, heart, lungs, stomach, bladder, kidneys, and limbs (hand and feet).

It also shows the fetus's growth status with placenta & umbilical cord location.

This scan offers a detailed view of the baby's heart structure and function. If abnormalities or changes are detected, the doctor will advise for further treatment.

This ultrasound is performed during the third trimester of pregnancy to assess whether the baby's growth is progressing as expected. It also evaluates the amount of amniotic fluid and the location of the placenta.

The lower position of the placenta and less amniotic fluid increases the risk of complications.

If detected at this stage, precautionary measures can be taken to ensure the best possible outcomes for both the mother and the foetus.

The doppler scan monitors blood flow in crucial areas of the body, including the brain, heart, and umbilical cord. If any abnormal changes are detected, the doctor may adjust the delivery date to ensure the best possible outcome for both mother and baby.

The biophysical profile (BPP) test shows heart rate monitoring (nonstress test), movement assessment, muscle tone evaluation, and amniotic fluid level measurement. Based on the results, the doctor decide further treatment plan.

A high-risk pregnancy is one where the serious complications for the mother and/or baby are higher than a normal pregnancy. Factors such as age, pregnancy-related conditions (gestational diabetes, multiples, pre-eclampsia, narrow cervix path, IUGR, etc.), and pre-existing maternal health conditions (heart disease, thyroid disorders, SLE, renal disease, infections, etc.) require careful monitoring.

Regular monitoring of a high-risk pregnancy requires periodic blood tests, urine exams, ultrasounds, glucose tolerance tests, and other essential evaluations advised by the doctor.